Olympic athletes to get free shots from Pfizer and BioNTech
The Swiss-based International Olympic Committee (IOC) says vaccine developers Pfizer and BioNTech will donate doses to inoculate athletes and officials gearing up for the Tokyo Olympics.
The doses will be delivered this month so that Olympic delegations can receive two shots before arriving in Tokyo for the opening of the games on July 23.
“We are inviting the athletes and participating delegations of the upcoming Olympic and Paralympic Games to lead by example and accept the vaccine where and when possible,” IOC President Thomas Bach said in a statement.
The Lausanne-based organisation said national Olympic committees will work with governments to coordinate local distribution in accordance with each country’s vaccination guidelines and regulations.
It also noted that the additional doses delivered by Pfizer and BioNTech will not be taken from existing programmes, but will be in addition to current quotas and planned deliveries worldwide.
It’s the second major vaccination deal for the IOC after an agreement in March with Chinese officials to buy and distribute Chinese vaccines ahead of the Tokyo Games and next year’s Beijing Winter Games.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
Japan and IOC agree to one-year delay to Tokyo 2020 Games
This content was published on
Switzerland’s top sports body has joined calls for the Tokyo 2020 Olympics to be postponed owing to the coronavirus pandemic.
This content was published on
When it comes to Swiss Olympic athletes, one trend in the data is particularly striking: There are no team players. That's not a value judgement.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.